EyePoint, Inc. (EYPT)
Nasdaq: EYPT · Laboratory Analytical Instruments · Watertown, MA · filing with the SEC since 2005
Who owns EyePoint, Inc.
As filed with the SECHolders of 5% or more
9
JANUS HENDERSON GROUP Ltd. holds 10.9% of Common Stock, as its SCHEDULE 13G filed Sep 8, 2026 says.
Directors and officers
11
report now, of 30 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 9 named at left.
Holders of 5% or moreshare of the class, as filed
JANUS HENDERSON GROUP Ltd.
SCHEDULE 13G · filed Sep 8, 2026 · Common Stock
Tang Capital Management, LLC
SCHEDULE 13G · filed Oct 27, 2026 · Common Stock, par value $0.001
Cormorant Asset Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 · 9.98% in Dec 8, 2025
Federated Hermes, Inc.
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK · 6.68% in Jul 8, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock · 6.5% in Oct 17, 2025
Franklin Resources, Inc.
SCHEDULE 13G/A · filed Jan 27, 2025 · Common Stock, par value $0.001 · 7.5% in Oct 31, 2024
Adage Capital Management, L.P.
SCHEDULE 13G · filed Aug 12, 2026 · Common Stock, par value $0.001 per share · 3.96% in May 13, 2026
Commodore Capital LP
SCHEDULE 13G · filed Jun 3, 2026 · Common Stock, par value $0.001
Vanguard Capital Management
SCHEDULE 13G · filed Jul 31, 2026 · Common Stock
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
TCG Crossover GP II, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%
Paradigm BioCapital Advisors LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 5.1% in Feb 24, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What EYPT reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 5, 2026.
Insider tradesForm 4
10sales
2purchases
10sales on a scheduled plan
2people selling
$1.1Msold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ribeiro Ramiro | Chief Medical Officer | 7 | $900,000 | 7 | 0 | $0 |
| Cormorant Asset Management, LP | 10% owner | 1 | $900,000 | 0 | 0 | $0 |
| Lurker Nancy | Executive Vice Chair | 3 | $200,000 | 3 | 0 | $0 |
| Duker Jay S. | President and CEO | 0 | $0 | 0 | 1 | $0 |
| Zaderej Karen L. | director | 0 | $0 | 0 | 1 | $100,000 |